Ildong Stock - BIO USA partnering push highlights pipeline ambitions
18.06.2026 - 15:38:26 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 15:36 KST. Details in the imprint.
Ildong (KR7249420008) is stepping onto the global stage again this week. According to a company announcement dated 06/18/2026, the Korean drugmaker will attend BIO USA 2026 to pitch its pipeline and pursue partnering activities.
All news and analysis on Ildong stock
Stay on top of developments around Ildong Pharmaceutical, from pipeline updates to partnering moves and stock data.
What the BIO USA move signals
According to a report from Asia Economy on 06/18/2026, Ildong Pharmaceutical Group said it will participate in BIO USA 2026 to introduce new drug candidates and seek business partnerships with global companies. The company highlights oncology and metabolic disease assets in its pipeline.
The BIO USA convention is one of the largest global partnering platforms in biotechnology, drawing big pharma, biotechs and investors each year. For a mid-sized Korean player like Ildong, visibility at such an event is a way to move beyond its home market.
Thursday focus on technical context
Ildong shares trade on Korea Exchange’s KOSPI market under the ticker 249420. Recent trading has taken place against a strong domestic backdrop, with the KOSPI index itself recently marking record territory for Korea’s capital market.
At the same time, individual mid-cap pharma names often show higher volatility than the broader index. For Ildong, liquidity and news flow around partnering or clinical milestones tend to drive interest more than macro moves in the benchmark.
How the company makes money
Ildong Pharmaceutical Co., Ltd. generates revenue mainly from prescription drugs, over-the-counter medicines, and functional health foods in South Korea and selected overseas markets. The group also invests in new drug R&D in oncology, metabolic diseases and other specialty areas.
Where the stock trades today
The shares of Ildong (KR7249420008) trade on the Korea Exchange KOSPI market at KRW 22,000.00 as of 06/18/2026, 15:30 KST.
Key facts on Ildong stock
- Company: Ildong Pharmaceutical Co., Ltd.
- ISIN: KR7249420008
- WKN: 249420
- Ticker: 249420
- Venue: KRX (KOSPI)
- Price (as of 06/18/2026, 15:30 KST): 22,000.00 KRW
- Market cap: 600,000,000,000 KRW (as of 06/18/2026)
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: none of the major global indices
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
